An observational study in Post-Traumatic Kyphosis, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-12-09.
Sponsored by Assiut University · Observational
The goal of this observational study is to examine the safety and efficacy of posterior sugary only in addressing post traumatic kyphosis. The main question[s]it aims to answer are:
Is it a safe procedure? Is it a sufficient approach to address deformity? Participants will be managed by posterior only surgery to address their deformity and will be assessed for the radiological and functional outcomes.
132 studies on the registry are indexed under Kyphosis; 31 are open to participants now.
This study's planned enrollment of 20 is below the median of 62 across 45 observational studies indexed under Kyphosis.
Browse Kyphosis studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
All patients with age range from 18-65 years old with PTK underwent posterior only corrective surgery and have been followed for at least 2 years with complete documentation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
change in degree of kyphosis
we will measure the kyphosis in pre operative radiogragh and post operative radiograph to detect the change in the degree and the correction achieved after posterior only operative correction
Time frame: 2 years
No study locations are listed for this record.
This study is not yet recruiting, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.